Overview

A Study of Duloxetine in Fibromyalgia

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the effectiveness and safety of duloxetine in participants with fibromyalgia.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Shionogi
Treatments:
Duloxetine Hydrochloride